Search results
-
The Transit Point Experiment (Spanish version)
Hammond, Janice H.; Kelly, MauraCase HBS-615S09Service and Operations ManagementMerloni Elettrodomestici is a leading Italian manufacturer of domestic appliances. In 1986, an exposition for Merloni customers is scheduled at its Milano regional warehouse. During the two-month period preceding the event, when the warehouse must be free of inventory, the company conducts a "transit point" experiment. Each day, a truckload of products from the company's central warehouse is sent to Milano, where it is immediately transferred to ...Starting at €8.20
-
PerkinElmer - Developing Products in China for China
Sato, Vicki L.; Jaeker, Christoph; Reda, KareemCase HBS-612032-EService and Operations ManagementTo maximize their effectiveness, color cases should be printed in color. Sym-Bio, an entrepreneurial Chinese diagnostic company with a product line in infectious disease testing, has agreed to be acquired by PerkinElmer, an international corporation with businesses in neonatal testing, life science services, and environmental health. Sym-Bio wants to accelerate its growth and competitive position in China through this strategic move, and PerkinEl...Starting at €8.20
-
Alnylam Pharmaceuticals: Building Value from the IP Estate (B)
Sato, Vicki L.; Shih, Willy; Higgins, MattCase HBS-617022-EService and Operations ManagementThe leader of a pioneering biotech company in the siRNA space weighs his options for scaling production capacity in advance of an anticipated commercial launch. Operational complexity and relative merits of in-house manufacturing versus a contractor model are discussed.Starting at €5.74
-
Adnexus Therapeutics, Inc.: Considering the Exit
Sato, Vicki L.; Gordon, RachelCase HBS-609015-EService and Operations ManagementDr. John Mendlein, CEO of Adnexus Therapeutics Inc., (Adnexus), a private biotechnology company, must decide whether to pursue acquisition talks with Bristol-Myers Squibb (BMS) after a successful six month collaboration or continue with Adnexus' planned IPO.Starting at €8.20